Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Serological and Molecular Analysis of Leishmania Infection in Healthy Individuals from Two Districts of West Bengal, India, Endemic for Visceral Leishmaniasis.

Kaushal H, Bhattacharya SK, Verma S, Salotra P.

Am J Trop Med Hyg. 2017 Jun;96(6):1448-1455. doi: 10.4269/ajtmh.16-0592.

PMID:
28719266
2.

Environmental factors associated with the distribution of visceral leishmaniasis in endemic areas of Bangladesh: modeling the ecological niche.

Abdullah AYM, Dewan A, Shogib MRI, Rahman MM, Hossain MF.

Trop Med Health. 2017 May 12;45:13. doi: 10.1186/s41182-017-0054-9. eCollection 2017.

3.

Development of a rapid loop-mediated isothermal amplification assay for diagnosis and assessment of cure of Leishmania infection.

Verma S, Singh R, Sharma V, Bumb RA, Negi NS, Ramesh V, Salotra P.

BMC Infect Dis. 2017 Mar 23;17(1):223. doi: 10.1186/s12879-017-2318-8.

4.

Elimination of visceral leishmaniasis in the Indian subcontinent: a comparison of predictions from three transmission models.

Le Rutte EA, Chapman LA, Coffeng LE, Jervis S, Hasker EC, Dwivedi S, Karthick M, Das A, Mahapatra T, Chaudhuri I, Boelaert MC, Medley GF, Srikantiah S, Hollingsworth TD, de Vlas SJ.

Epidemics. 2017 Mar;18:67-80. doi: 10.1016/j.epidem.2017.01.002.

5.

Chronic Arsenic Exposure and Risk of Post Kala-azar Dermal Leishmaniasis Development in India: A Retrospective Cohort Study.

Das S, Mandal R, Rabidas VN, Verma N, Pandey K, Ghosh AK, Kesari S, Kumar A, Purkait B, Lal CS, Das P.

PLoS Negl Trop Dis. 2016 Oct 24;10(10):e0005060. doi: 10.1371/journal.pntd.0005060. eCollection 2016 Oct.

6.

Post-Kala-Azar Dermal Leishmaniasis Without Previous History of Visceral Leishmaniasis.

Hasnain G, Shomik MS, Ghosh P, Rashid MO, Hossain S, Hamano S, Mondal D.

Am J Trop Med Hyg. 2016 Dec 7;95(6):1383-1385. Epub 2016 Sep 26.

PMID:
27672208
7.

A review of visceral leishmaniasis during the conflict in South Sudan and the consequences for East African countries.

Al-Salem W, Herricks JR, Hotez PJ.

Parasit Vectors. 2016 Aug 22;9:460. doi: 10.1186/s13071-016-1743-7. Review.

8.

Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent - A Systematic Literature Review.

Hirve S, Boelaert M, Matlashewski G, Mondal D, Arana B, Kroeger A, Olliaro P.

PLoS Negl Trop Dis. 2016 Aug 4;10(8):e0004896. doi: 10.1371/journal.pntd.0004896. eCollection 2016 Aug.

9.

Measures to Control Phlebotomus argentipes and Visceral Leishmaniasis in India.

Bublitz DC, Poché RM, Garlapati R.

J Arthropod Borne Dis. 2016 Jan 5;10(2):113-26. eCollection 2016 Jun. Review.

11.

Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India.

Kaushal H, Bras-Gonçalves R, Avishek K, Kumar Deep D, Petitdidier E, Lemesre JL, Papierok G, Kumar S, Ramesh V, Salotra P.

Clin Exp Immunol. 2016 Jul;185(1):50-60. doi: 10.1111/cei.12787. Epub 2016 May 4.

12.

Feasibility of eliminating visceral leishmaniasis from the Indian subcontinent: explorations with a set of deterministic age-structured transmission models.

Le Rutte EA, Coffeng LE, Bontje DM, Hasker EC, Postigo JA, Argaw D, Boelaert MC, De Vlas SJ.

Parasit Vectors. 2016 Jan 19;9:24. doi: 10.1186/s13071-016-1292-0.

13.

PKDL--A Silent Parasite Pool for Transmission of Leishmaniasis in Kala-azar Endemic Areas of Malda District, West Bengal, India.

Ganguly S, Saha P, Chatterjee M, Roy S, Ghosh TK, Guha SK, Kundu PK, Bera DK, Basu N, Maji AK.

PLoS Negl Trop Dis. 2015 Oct 20;9(10):e0004138. doi: 10.1371/journal.pntd.0004138. eCollection 2015.

14.

Active and passive case detection strategies for the control of leishmaniasis in Bangladesh.

Das AK, Harries AD, Hinderaker SG, Zachariah R, Ahmed B, Shah GN, Khogali MA, Das GI, Ahmed EM, Ritmeijer K.

Public Health Action. 2014 Mar 21;4(1):15-21. doi: 10.5588/pha.13.0084.

15.

Performance of kala-azar surveillance in Gaffargaon subdistrict of Mymensingh, Bangladesh.

Rahman KM, Samarawickrema IV, Harley D, Olsen A, Butler CD, Sumon SA, Biswas SK, Luby SP, Sleigh AC.

PLoS Negl Trop Dis. 2015 Apr 10;9(4):e0003531. doi: 10.1371/journal.pntd.0003531. eCollection 2015 Apr.

16.

Hypokalaemia-induced rhabdomyolysis after treatment of post-Kala-azar dermal Leishmaniasis (PKDL) with high-dose AmBisome in Bangladesh-a case report.

Marking U, den Boer M, Das AK, Ahmed EM, Rollason V, Ahmed BN, Davidson RN, Ritmeijer K.

PLoS Negl Trop Dis. 2014 Jun 12;8(6):e2864. doi: 10.1371/journal.pntd.0002864. eCollection 2014 Jun. No abstract available.

17.

Model-based investigations of different vector-related intervention strategies to eliminate visceral leishmaniasis on the Indian subcontinent.

Stauch A, Duerr HP, Picado A, Ostyn B, Sundar S, Rijal S, Boelaert M, Dujardin JC, Eichner M.

PLoS Negl Trop Dis. 2014 Apr 24;8(4):e2810. doi: 10.1371/journal.pntd.0002810. eCollection 2014 Apr.

18.

Post Kala-Azar dermal leishmaniasis following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India.

Burza S, Sinha PK, Mahajan R, Sanz MG, Lima MA, Mitra G, Verma N, Das P.

PLoS Negl Trop Dis. 2014 Jan 2;8(1):e2611. doi: 10.1371/journal.pntd.0002611. eCollection 2014.

19.

Post kala-azar dermal leishmaniasis: an unresolved mystery.

Mukhopadhyay D, Dalton JE, Kaye PM, Chatterjee M.

Trends Parasitol. 2014 Feb;30(2):65-74. doi: 10.1016/j.pt.2013.12.004. Epub 2014 Jan 2. Review.

20.

Supplemental Content

Support Center